Microglia are prominent producers of inflammatory cytokines during the hyperacute phase of ischemic stroke
Top Cited Papers
Open Access
- 10 August 2025
- journal article
- Published by Springer Nature in Communications Biology
- Vol. 8 (1) , 1193
Abstract
Current treatments for ischemic stroke focus on removing neurovascular-occluding clots but overlook the resulting neuroinflammation. Clinical trials targeting brain-infiltrating peripheral immune cells have failed to improved outcomes, leaving mechanisms of neuroinflammation poorly understood. Whilst many studies have examined the inflammatory cells and cytokine profile of the post-stroke brain at days and weeks following injury onset, we propose that interventions at these timepoints are too late to limit brain damage. In this study, we examined brain immune cell composition, cytokine levels, and neurological dysfunction at hyperacute (3 h) and acute (24 h) stages following a preclinical mouse model of ischemic stroke. Interestingly, we detected elevated inflammatory cytokines in brain tissue as early as 3 h, notably before infiltrating neutrophil and monocyte arrival at 24 h. Depletion of peripheral immune cells by antibodies or genetic alteration did not dampen neuroinflammation, nor improve sensorimotor function. Intravital imaging of Cx3cr1gfp/+ mice showed that microglia, the brain-resident immune cell, display rapidly altered morphology, and swiftly upregulated cytokine production hyperacutely post-stroke. Altogether, our study provides evidence that microglia are key drivers of early neuroinflammation and modulating their function at clinically-relevant timepoints will improve stroke recovery.Keywords
This publication has 71 references indexed in Scilit:
- Targeting the Ischemic PenumbraStroke, 2011
- Selective Chemokine Receptor Usage by Central Nervous System Myeloid Cells in CCR2-Red Fluorescent Protein Knock-In MicePLOS ONE, 2010
- The adhesive removal test: a sensitive method to assess sensorimotor deficits in miceNature Protocols, 2009
- Systemic Inflammatory Stimulus Potentiates the Acute Phase and CXC Chemokine Responses to Experimental Stroke and Exacerbates Brain Damage via Interleukin-1- and Neutrophil-Dependent MechanismsJournal of Neuroscience, 2007
- Absence of the Chemokine Receptor CCR2 Protects Against Cerebral Ischemia/Reperfusion Injury in MiceStroke, 2007
- Acute Stroke Therapy by Inhibition of Neutrophils (ASTIN)Stroke, 2003
- Analysis of Fractalkine Receptor CX3CR1 Function by Targeted Deletion and Green Fluorescent Protein Reporter Gene InsertionMolecular and Cellular Biology, 2000
- Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2Proceedings of the National Academy of Sciences, 1997
- Dynamics of Polymorphonuclear Leukocyte Accumulation in Acute Cerebral Infarction and Their Correlation With Brain Tissue DamageStroke, 1996
- Role of cell adhesion molecules in brain injury after transient middle cerebral artery occlusion in the ratBrain Research, 1994